ChemicalBook >> CAS DataBase List >>Spartalizumab

Spartalizumab

Spartalizumab structure

CAS No.: 1935694-88-4

Chemical Name:: Spartalizumab

Synonyms: PDR001;Spartalizumab;Spartalizumab (anti-PD-1);Research Grade Spartalizumab;Research Grade Spartalizumab (DHH02214)

CBNumber:: CB48081049

Molecular Formula:

Molecular Weight:: 0

MDL Number:

MOL File:: Mol file

MSDS File:: SDS

TDS File:: TDS

Last updated:2026-04-24 14:58:33

Request For Quotation

Spartalizumab Properties

form	Liquid
color	Colorless to light yellow
FDA UNII	QOG25L6Z8Z
NCI Drug Dictionary	spartalizumab

Spartalizumab price

Manufacturer	Product number	Product description	CAS number	Packaging	Price	Updated	Buy
ChemScene	CS-0142322	Spartalizumab 99.50%	1935694-88-4	1mg	$238	2026-06-04	Buy
ChemScene	CS-0142322	Spartalizumab 99.50%	1935694-88-4	5mg	$704	2026-06-04	Buy
ChemScene	CS-0142322	Spartalizumab 99.50%	1935694-88-4	10mg	$1197	2026-06-04	Buy
aablocks	AA02409S	Spartalizumab (anti-PD-1)	1935694-88-4	1mg	$163	2026-06-01	Buy
Arctom	HY-P9972	Spartalizumab 99.50%	1935694-88-4	1mg	$209	2026-05-26	Buy

Product number	Packaging	Price	Buy
CS-0142322	1mg	$238	Buy
CS-0142322	5mg	$704	Buy
CS-0142322	10mg	$1197	Buy
AA02409S	1mg	$163	Buy
HY-P9972	1mg	$209	Buy

Spartalizumab Chemical Properties,Uses,Production

Uses

Spartalizumab (PDR001) is a humanized immunoglobulin 4 monoclonal antibody that binds PD-1 with subnanomolar activity and blocks interaction with PD-L1 and PD-L2. Spartalizumab can be used for the research of anaplastic thyroid carcinoma (ATC)[1].

References

[1] Jaume Capdevila, et al. PD-1 Blockade in Anaplastic Thyroid Carcinoma. J Clin Oncol. 2020 Aug 10;38(23):2620-2627. DOI:10.1200/JCO.19.02727

Spartalizumab Preparation Products And Raw materials

Raw materials

Preparation Products

Spartalizumab Suppliers

Global( 28)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
Shanghai YuanYe Biotechnology Co., Ltd.	15026964105	2881489226@qq.com	China	89667	60
ShangHai Biochempartner Co.,Ltd	177-54423994 17754423994	2853530910@QQ.com	China	8000	62
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1577	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10305	58
Beijing Jin Ming Biotechnology Co., Ltd.	010-60605840	psaitong@jm-bio.com	China	27626	58
TargetMol Chemicals Inc.	4008200310 15002144251	marketing@tsbiochem.com	China	24951	58
Biolab Reagents	027-65279366 18108604356	products@biolabreagent.com	China	9864	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 086-15871494362 13720134139	orders@jknbiochem.com	China	7283	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11963	58
Wuhan Acumen Bio-Technology Co.,ltd	027-027-16602739303 16602739303	673003916@qq.com	China	4593	58

Supplier	Advantage
Shanghai YuanYe Biotechnology Co., Ltd.	60
ShangHai Biochempartner Co.,Ltd	62
Guangzhou Hongyuan Chemical Co.,Ltd	58
Wuhan Chemstan Biotechnology Co., Ltd.	58
Beijing Jin Ming Biotechnology Co., Ltd.	58
TargetMol Chemicals Inc.	58
Biolab Reagents	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	58
Shanghai Yifei Biotechnology Co. , Ltd.	58
Wuhan Acumen Bio-Technology Co.,ltd	58

1935694-88-4(Spartalizumab)Related Search:

Plamotamab Ivicentamab Lymphocide Cergutuzumab Amunaleukin Ezabenlimab

Keliximab Regavirumab Lupartumab Modotuximab Anrukinzumab

1of2

Spartalizumab Research Grade Spartalizumab (DHH02214) Research Grade Spartalizumab Spartalizumab (anti-PD-1) PDR001 1935694-88-4